Artículo
Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
Autor/es | Santos, Marta
Corma Gómez, Anais Martin Carmona, Jesica Perez Garcia, Margarita Martin Sierra, Carmen Rincón Mayo, Pilar González Serna, Alejandro Pineda, Juan Antonio Real, Luis Miguel Macias, Juan |
Departamento | Universidad de Sevilla. Departamento de Fisiología |
Fecha de publicación | 2023-10-31 |
Fecha de depósito | 2024-04-04 |
Publicado en |
|
Resumen | Lockdown due to the coronavirus disease 2019 (COVID-19) pandemic led to increases in weight in part of the
population. Weight gain leads to hepatic steatosis (HS). Antiretroviral treatment could also influence HS in people ... Lockdown due to the coronavirus disease 2019 (COVID-19) pandemic led to increases in weight in part of the population. Weight gain leads to hepatic steatosis (HS). Antiretroviral treatment could also influence HS in people with human immunodeficiency virus (PWH). The impact of lockdown on HS in PWH is unknown. The aim of this study was to analyze the changes in HS, as measured by the controlled attenuation parameter (CAP), during the COVID-19 pandemic in PWH. |
Agencias financiadoras | Instituto de Salud Carlos III Fondos Europeos FEDER |
Identificador del proyecto | PI018/00606 |
Cita | Santos, M., Corma Gómez, A., Martin Carmona, J., Perez Garcia, M., Martin Sierra, C., Rincón Mayo, P.,...,Macias, J. (2023). Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide. Open Forum Infectious Diseases, 10 (11), ofad532. https://doi.org/10.1093/ofid/ofad532. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
ofad532.pdf | 557.8Kb | [PDF] | Ver/ | |